Revance Receives Permanent J-Code for DAXXIFY® and Anno

- CMS streamlines reimbursement for DAXXIFY with assignment of permanent J-code -


- Peer-reviewed publication of DAXXIFY pivotal data in therapeutics reinforces the products long duration of effect...

Related Keywords

United States , China , American , Cynthial Comella , Markj Foley , , Dystonia Medical Research Foundation , Drug Administration , Securities Exchange , Exchange Commission , Revance Therapeutics Inc , Peptide Exchange Technology , Linkedin , Viatris Inc , American Academy Of Neurology , Us Centers For Medicare Medicaid Services , Revance Therapeutics , Medicaid Services , American Academy , Chief Executive , Atul Patel , Boxed Warning , Distant Spread , Specific Populations , Prescribing Information , Shanghai Fosun Pharmaceutical , Resilient Hyaluronic Acid , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Markets ,